Phathom Pharmaceuticals, Inc.
← Back to PHAT Overview

Phathom Pharmaceuticals, Inc. (PHAT)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-12.92

Financial Fundamentals

PHATQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2018-03-31-127.59
2018-06-30-127.59
2018-09-30-181.95
2018-12-31-109.04
2019-03-31-41.00
2019-06-30-0.60
2019-09-30-2.06
2019-12-31-2.58
2020-03-31-10.41
2020-06-30-12.86
2020-09-30-8.99
2020-12-31-5.26
2021-03-31-9.78
2021-06-30-8.46
2021-09-30-8.19
2021-12-31-5.18
2022-03-31-2.98
2022-06-30-1.59
2022-09-30-1.80
2022-12-31-1.82
2023-03-31-2.01
2023-06-30-4.26
2023-09-30-3.41
2023-12-31-1.64
2024-03-31-1.87
2024-06-30-1.73
2024-09-30-3.42
2024-12-31-1.93
2025-03-31-1.20
2025-06-30-2.28
2025-09-30-7.18
2025-12-31-14.30
2026-03-31-7.51
2026-06-30-12.92

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.